LIU Jia-qi, MEI Shi-qi, ZHOU Qing. Pembrolizumab Plus Chemotherapy in Metastatic Squamous Non-Small-Cell Lung Cancer: 5-Year Update of KEYNOTE-407 Study[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 197-202. DOI: 10.12019/j.issn.1671-5144.2023.04.002
|
Citation:
|
LIU Jia-qi, MEI Shi-qi, ZHOU Qing. Pembrolizumab Plus Chemotherapy in Metastatic Squamous Non-Small-Cell Lung Cancer: 5-Year Update of KEYNOTE-407 Study[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 197-202. DOI: 10.12019/j.issn.1671-5144.2023.04.002
|
LIU Jia-qi, MEI Shi-qi, ZHOU Qing. Pembrolizumab Plus Chemotherapy in Metastatic Squamous Non-Small-Cell Lung Cancer: 5-Year Update of KEYNOTE-407 Study[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 197-202. DOI: 10.12019/j.issn.1671-5144.2023.04.002
|
Citation:
|
LIU Jia-qi, MEI Shi-qi, ZHOU Qing. Pembrolizumab Plus Chemotherapy in Metastatic Squamous Non-Small-Cell Lung Cancer: 5-Year Update of KEYNOTE-407 Study[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 197-202. DOI: 10.12019/j.issn.1671-5144.2023.04.002
|
DownLoad: